FILOSSO, Pier Luigi
 Distribuzione geografica
Continente #
AS - Asia 9.664
NA - Nord America 7.980
EU - Europa 3.459
SA - Sud America 1.044
Continente sconosciuto - Info sul continente non disponibili 298
AF - Africa 104
OC - Oceania 17
Totale 22.566
Nazione #
US - Stati Uniti d'America 7.685
CN - Cina 3.434
SG - Singapore 2.772
HK - Hong Kong 1.105
IT - Italia 977
BR - Brasile 834
KR - Corea 665
FI - Finlandia 589
GB - Regno Unito 552
BD - Bangladesh 543
VN - Vietnam 541
DE - Germania 315
RU - Federazione Russa 260
FR - Francia 191
CA - Canada 153
SE - Svezia 139
IN - India 92
LT - Lituania 89
NL - Olanda 89
ID - Indonesia 84
AR - Argentina 82
TR - Turchia 71
JP - Giappone 64
MX - Messico 57
IQ - Iraq 48
AE - Emirati Arabi Uniti 42
IE - Irlanda 39
EC - Ecuador 29
UA - Ucraina 29
ES - Italia 28
PK - Pakistan 27
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
CO - Colombia 22
MY - Malesia 22
AT - Austria 20
CL - Cile 20
JM - Giamaica 20
PH - Filippine 18
PL - Polonia 18
SA - Arabia Saudita 18
ZA - Sudafrica 18
BE - Belgio 17
TH - Thailandia 16
VE - Venezuela 16
CR - Costa Rica 15
DZ - Algeria 15
AU - Australia 14
UY - Uruguay 14
JO - Giordania 13
EG - Egitto 12
MA - Marocco 12
PE - Perù 12
PY - Paraguay 12
RO - Romania 12
NI - Nicaragua 11
NP - Nepal 10
SC - Seychelles 10
BG - Bulgaria 9
CH - Svizzera 9
PT - Portogallo 9
AZ - Azerbaigian 8
HN - Honduras 8
KE - Kenya 7
LB - Libano 7
TN - Tunisia 7
AL - Albania 6
BY - Bielorussia 6
MD - Moldavia 6
SV - El Salvador 6
AO - Angola 5
BH - Bahrain 5
ET - Etiopia 5
PS - Palestinian Territory 5
DK - Danimarca 4
GR - Grecia 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
OM - Oman 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
DM - Dominica 2
GA - Gabon 2
GE - Georgia 2
KH - Cambogia 2
KN - Saint Kitts e Nevis 2
LV - Lettonia 2
MN - Mongolia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
VG - Isole Vergini Britanniche 2
Totale 22.241
Città #
Hefei 2.371
Singapore 1.734
Santa Clara 1.616
Hong Kong 1.071
Council Bluffs 1.012
Ashburn 901
San Jose 665
Seoul 659
Helsinki 559
London 421
Los Angeles 294
The Dalles 286
Milan 205
Ho Chi Minh City 175
Beijing 171
New York 166
Chicago 160
Lauterbourg 138
Kent 130
Buffalo 125
Munich 125
Hanoi 122
Boardman 102
Moscow 94
Shanghai 91
Dallas 84
Rome 74
Jakarta 66
Falkenstein 65
Frankfurt am Main 63
Amsterdam 62
São Paulo 58
Columbus 53
Nyköping 49
Atlanta 47
Salt Lake City 47
Istanbul 42
Dublin 39
Da Nang 37
Miano 37
Phoenix 36
Toronto 35
Kilburn 34
Redondo Beach 34
Rio de Janeiro 32
Tokyo 32
Bologna 31
Turin 31
Tampa 29
Charlotte 28
Brooklyn 27
Elk Grove Village 27
Miami 27
Orem 26
Nashville 25
North Bergen 24
Haiphong 22
Houston 22
Mexico City 22
Modena 22
Washington 22
Tashkent 21
Brno 20
Naples 20
Curitiba 19
Guangzhou 19
Hounslow 18
Boston 17
San Francisco 17
Sterling 17
Belo Horizonte 16
Hangzhou 16
Hillsboro 16
Ravenna 16
Wilmington 16
Florence 15
Kingston 15
Philadelphia 15
Detroit 14
Lancaster 14
Memphis 14
Ottawa 14
Shenzhen 14
Turku 14
Amman 13
Baghdad 13
Biên Hòa 13
Denver 13
Montreal 13
Nagoya 13
Nuremberg 13
Porto Alegre 13
Brasília 12
Campinas 12
Guayaquil 12
Jersey City 12
Kuala Lumpur 12
Orlando 12
Palermo 12
Santo André 12
Totale 15.381
Nome #
Proctor-guided virtual reality-enhanced three-dimensional video-assisted thoracic surgery: an excellent tutoring model for lung segmentectomy 269
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC 262
ESTS Textbook of thoracic Surgery. Cap. 10.1: Postero-lateral thoracotomy 226
Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy 214
Integrated endoscopic treatment of primitive unresectable tracheal tumor: the INTACT retrospective cohort study. 197
Large cell neuroendocrine carcinoma of the lung: A retrospective analysis of 144 surgical cases 195
Errors and Complications in Chest Tube Placement 193
Outcome of surgically resected thymic carcinoma: A multicenter experience 192
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids 189
Prognostic score for survival with pulmonary carcinoids: The importance of associating clinical with pathological characteristics 187
Adenosquamous lung carcinomas: A histologic subtype with poor prognosis 187
Outcome of primary neuroendocrine tumors of the thymus: A joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases 183
Bronchial carcinoid tumors: surgical management and long-term outcome 179
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer 173
[Neuroendocrine tumors of the lung] 172
Accuracy of F-18-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification 166
Bronchopulmonary Carcinoids causing Cushing Syndrome: Results from a Multicentric Study Suggesting a More Aggressive Behavior 165
Chest drain and thoracotomy for chest trauma 164
The IASLC Lung Cancer Staging Project: A Renewed Call to Participation 163
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma 162
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids 162
The International Thymic Malignancy Interest Group Classification of Thymoma Recurrence: Survival Analysis and Perspectives 160
Reconstruction of Complex Anterior Chest Wall Defects: The Lasagna Technique 159
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids 158
Bilateral pneumothorax, pneumonia, and pneumomediastinum after injection of a hard drug into the neck 150
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 149
The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system 148
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification 146
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 145
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 145
Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta 142
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest) 141
The IASLC lung cancer staging project: Background data and proposals for the application of TNM staging rules to lung cancer presenting as multiple nodules with ground glass or lepidic features or a pneumonic type of involvement in the forthcoming eighth edition of the TNM classification 140
Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study 139
Solitary fibrous tumour of the pleura: surgical treatment 139
Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? 139
Prognostic model of survival for typical bronchial carcinoid tumours: Analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group 138
The IASLC lung cancer staging project: Background data and proposals for the classification of lung cancer with separate tumor nodules in the forthcoming eighth edition of the TNM classification for lung cancer 138
Management of bronchial carcinoids: International practice survey among the European Society of Thoracic Surgeons 137
Addressing a missing point: The short- and long-term effects of a lung sealant patch 136
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 135
Exploring Stage I non-small cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection 135
Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients 135
[Bronchopulmonary carcinoid tumours] 135
Outcome and prognostic factors in bronchial carcinoids: a single-center experience 133
Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 Pandemic 132
Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series 132
External Validation of a Prognostic Score for Survival in Lung Carcinoids 131
Atypical bronchial carcinoids. Review of 46 patients 131
Pulmonary metastases from epithelial tumours: late results of surgical treatment 131
[Post-traumatic right diaphragmatic hernia. Description of a clinical case] 130
Chest Drainage Management: Where Are We Now? 129
Neuroendocrine tumors of the thymus 129
Il‐17 promotes nitric oxide production in non‐small‐cell lung cancer 129
Efficacy and safety of human fibrinogen-thrombin patch (TachoSil®) in the treatment of postoperative air leakage in patients submitted to redo surgery for lung malignancies: a randomized trial 128
The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors 128
Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience 128
The European Society of Thoracic Surgeons (ESTS) lung neuroendocrine tumors (NETs) database 127
Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: A European Society of Thoracic Surgeons Thymic Working Group Study 127
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease 125
Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms 124
Thymic carcinoma outcomes and prognosis: results of an international analysis 124
Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature 122
Resection for bronchogenic carcinoma in the elderly 122
Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection 120
The European Society of Thoracic Surgeons (ESTS) thymic database 119
Cenni di Anatomia 118
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database 118
Management of Chest Drains After Thoracic Resections 118
External Validation of a Prognostic Model for Squamous-Cell Lung Cancer and Impact of Adjuvant Treatment in >1,300 Patients: Topic: Neoadjuvant and Adjuvant Chemotherapy 117
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) 117
Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience 116
Functional imaging evaluation in the detection, diagnosis, and histologic differentiation of pulmonary neuroendocrine tumors 116
Application of the coaxial smart drain in patients with a large air leak following anatomic lung resection: a prospective multicenter phase II analysis of efficacy and safety 116
Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exists? 115
Benign fibrous mesothelioma of the pleura 115
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 115
Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study 114
Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients 114
The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors 113
Neuroendocrine tumors of the thymus 113
Extended transcervical thymectomy with partial upper sternotomy: Results in non-thymomatous patients with myasthenia gravis 113
Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size 112
Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura 112
Completion pneumonectomy: a multicentre international study on 165 patients 111
KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer 110
How to design a randomized clinical trial: Tips and tricks for conduct a successful study in thoracic disease domain 110
Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide 109
The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression 109
Emerging treatment options in the management of non-small cell lung cancer 108
Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer 107
Optimal surgical approach to thymic malignancies: New trends challenging old dogmas 107
Historical perspectives: The evolution of the thymic epithelial tumors staging system 106
Surgical management of chronic diaphragmatic hernias 105
Post-traumatic hernia of the lung 104
The influence of tissue ischemia time on RNA integrity and patient-derived xenografts (PDX) engraftment rate in a non-small cell lung cancer (NSCLC) Biobank 104
Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis 104
Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms 104
Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients 104
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series 104
Totale 13.868
Categoria #
all - tutte 126.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023242 0 0 0 0 0 0 137 24 38 9 21 13
2023/20241.305 15 17 133 75 214 68 83 136 48 71 161 284
2024/20256.514 237 20 58 296 1.226 760 210 409 623 601 997 1.077
2025/202613.221 1.125 923 1.556 1.329 635 646 1.627 495 1.042 963 1.901 979
2026/20271.284 550 734 0 0 0 0 0 0 0 0 0 0
Totale 22.566